Radhakrishnan P. Iyer
Keine laufenden Positionen mehr
Profil
Radhakrishnan P.
Iyer was the founder of OriGene Technologies, Inc. (founded in 1998) where he held the title of Vice President-Discovery from 1998 to 2002.
He was also the founder of F-Star Therapeutics, Inc. (United States) (founded in 2002) where he held the title of Director & Chief Scientific Officer.
Dr. Iyer's former job positions include Senior Scientist & Associate Director at Idera Pharmaceuticals, Inc. from 1993 to 1998 and Professor at the University of Mumbai.
Dr. Iyer's education history includes a doctorate from the University of the Pacific and undergraduate and graduate degrees from the University of Mumbai.
Ehemalige bekannte Positionen von Radhakrishnan P. Iyer
| Unternehmen | Position | Ende |
|---|---|---|
| SPRING BANK PHARMACEUTICALS, INC. | Gründer | 20.11.2020 |
OriGene Technologies, Inc.
 OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services OriGene Technologies, Inc. engages in the development of products for pharmaceutical, biotechnology, and academic research. It offers CDNA clones, antibodies, assay kits, vectors, RNA Interference (RNAi), tissues, proteins, genome editing, and other products. The company was founded by Wei-Wu He in 1996 and is headquartered in Rockville, MD. | Gründer | 01.01.2002 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
| University of Mumbai | Corporate Officer/Principal | - |
Ausbildung von Radhakrishnan P. Iyer
| University of the Pacific | Doctorate Degree |
| University of Mumbai | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
OriGene Technologies, Inc.
OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services OriGene Technologies, Inc. engages in the development of products for pharmaceutical, biotechnology, and academic research. It offers CDNA clones, antibodies, assay kits, vectors, RNA Interference (RNAi), tissues, proteins, genome editing, and other products. The company was founded by Wei-Wu He in 1996 and is headquartered in Rockville, MD. | Commercial Services |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
